• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FUS/TLS 缺陷导致的行为和病理异常与肌萎缩侧索硬化症不同。

FUS/TLS deficiency causes behavioral and pathological abnormalities distinct from amyotrophic lateral sclerosis.

机构信息

Department of Neuroscience for Neurodegenerative Disorders, Juntendo University Graduate School of Medicine, Tokyo, Japan.

CREST (Core Research for Evolutionary Science and Technology), JST, Saitama, Japan.

出版信息

Acta Neuropathol Commun. 2015 Apr 25;3:24. doi: 10.1186/s40478-015-0202-6.

DOI:10.1186/s40478-015-0202-6
PMID:25907258
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4408580/
Abstract

INTRODUCTION

FUS/TLS is an RNA-binding protein whose genetic mutations or pathological inclusions are associated with neurological diseases including amyotrophic lateral sclerosis (ALS), frontotemporal lobar degeneration, and essential tremor (ET). It is unclear whether their pathogenesis is mediated by gain or loss of function of FUS/TLS.

RESULTS

Here, we established outbred FUS/TLS knockout mice to clarify the effects of FUS/TLS dysfunction in vivo. We obtained homozygous knockout mice that grew into adulthood. Importantly, they did not manifest ALS- or ET-like phenotypes until nearly two years. Instead, they showed distinct histological and behavioral alterations including vacuolation in hippocampus, hyperactivity, and reduction in anxiety-like behavior. Knockout mice showed transcriptome alterations including upregulation of Taf15 and Hnrnpa1, while they have normal morphology of RNA-related granules such as Gems.

CONCLUSIONS

Collectively, FUS/TLS depletion causes phenotypes possibly related to neuropsychiatric and neurodegenerative conditions, but distinct from ALS and ET, together with specific alterations in RNA metabolisms.

摘要

简介

FUS/TLS 是一种 RNA 结合蛋白,其基因突变或病理性包含物与包括肌萎缩侧索硬化症 (ALS)、额颞叶痴呆和特发性震颤 (ET) 在内的神经退行性疾病有关。其发病机制是通过 FUS/TLS 的功能获得还是丧失来介导的尚不清楚。

结果

在这里,我们建立了远交系 FUS/TLS 敲除小鼠,以阐明 FUS/TLS 功能障碍在体内的作用。我们获得了能够成年的纯合敲除小鼠。重要的是,它们直到近 2 岁才表现出 ALS 或 ET 样表型。相反,它们表现出明显的组织学和行为改变,包括海马空泡化、过度活跃和焦虑样行为减少。敲除小鼠表现出转录组改变,包括 Taf15 和 Hnrnpa1 的上调,而它们的 RNA 相关颗粒(如 Gems)形态正常。

结论

总之,FUS/TLS 缺失导致的表型可能与神经精神和神经退行性疾病有关,但与 ALS 和 ET 不同,同时伴有 RNA 代谢的特定改变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d6a/4408580/105144029327/40478_2015_202_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d6a/4408580/5860dc232afe/40478_2015_202_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d6a/4408580/c1c4b26542b0/40478_2015_202_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d6a/4408580/cc2ed79ad5c3/40478_2015_202_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d6a/4408580/634be4a27b57/40478_2015_202_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d6a/4408580/105144029327/40478_2015_202_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d6a/4408580/5860dc232afe/40478_2015_202_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d6a/4408580/c1c4b26542b0/40478_2015_202_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d6a/4408580/cc2ed79ad5c3/40478_2015_202_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d6a/4408580/634be4a27b57/40478_2015_202_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d6a/4408580/105144029327/40478_2015_202_Fig5_HTML.jpg

相似文献

1
FUS/TLS deficiency causes behavioral and pathological abnormalities distinct from amyotrophic lateral sclerosis.FUS/TLS 缺陷导致的行为和病理异常与肌萎缩侧索硬化症不同。
Acta Neuropathol Commun. 2015 Apr 25;3:24. doi: 10.1186/s40478-015-0202-6.
2
Nuclear transport impairment of amyotrophic lateral sclerosis-linked mutations in FUS/TLS.核转运障碍导致肌萎缩侧索硬化症相关 FUS/TLS 突变。
Ann Neurol. 2011 Jan;69(1):152-62. doi: 10.1002/ana.22246. Epub 2010 Dec 8.
3
FUS/TLS acts as an aggregation-dependent modifier of polyglutamine disease model mice.FUS/TLS作为多聚谷氨酰胺疾病模型小鼠的聚集依赖性修饰因子发挥作用。
Sci Rep. 2016 Oct 14;6:35236. doi: 10.1038/srep35236.
4
Transportin 1 accumulates specifically with FET proteins but no other transportin cargos in FTLD-FUS and is absent in FUS inclusions in ALS with FUS mutations.转运蛋白 1 特异性地与 FET 蛋白积聚,但在 FTLD-FUS 中没有其他转运蛋白货物,并且在 FUS 突变的 ALS 中 FUS 包涵体中不存在。
Acta Neuropathol. 2012 Nov;124(5):705-16. doi: 10.1007/s00401-012-1020-6. Epub 2012 Jul 28.
5
FET proteins in frontotemporal dementia and amyotrophic lateral sclerosis.额颞叶痴呆和肌萎缩侧索硬化症中的 FET 蛋白。
Brain Res. 2012 Jun 26;1462:40-3. doi: 10.1016/j.brainres.2011.12.010. Epub 2011 Dec 13.
6
FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.FET 蛋白 TAF15 和 EWS 是选择性标志物,可将 FUS 病理的 FTLD 与 FUS 突变的肌萎缩侧索硬化症区分开来。
Brain. 2011 Sep;134(Pt 9):2595-609. doi: 10.1093/brain/awr201. Epub 2011 Aug 19.
7
FUS mutations in frontotemporal lobar degeneration with amyotrophic lateral sclerosis.额颞叶变性伴运动神经元病中的 FUS 突变。
J Alzheimers Dis. 2010;22(3):765-9.
8
Aggregation of ALS-linked FUS mutant sequesters RNA binding proteins and impairs RNA granules formation.ALS 相关 FUS 突变体的聚集会隔离 RNA 结合蛋白并损害 RNA 颗粒的形成。
Biochem Biophys Res Commun. 2014 Sep 26;452(3):600-7. doi: 10.1016/j.bbrc.2014.08.115. Epub 2014 Aug 28.
9
Fused in sarcoma/translocated in liposarcoma: a multifunctional DNA/RNA binding protein.融合在肉瘤/易位在脂肪肉瘤:一种多功能的 DNA/RNA 结合蛋白。
Int J Biochem Cell Biol. 2010 Sep;42(9):1408-11. doi: 10.1016/j.biocel.2010.06.003. Epub 2010 Jun 10.
10
Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis.评估 FUS/TLS 相关基因 EWSR1 在肌萎缩侧索硬化症中的作用。
Hum Mol Genet. 2012 Jul 1;21(13):2899-911. doi: 10.1093/hmg/dds116. Epub 2012 Mar 27.

引用本文的文献

1
Identification of Splicing Regulatory Activity of ATXN1 and Its Associated Domains.脊髓小脑共济失调1型(ATXN1)及其相关结构域剪接调控活性的鉴定
Biomolecules. 2025 May 28;15(6):782. doi: 10.3390/biom15060782.
2
RNA-binding proteins in ALS and FTD: from pathogenic mechanisms to therapeutic insights.肌萎缩侧索硬化症和额颞叶痴呆中的RNA结合蛋白:从致病机制到治疗见解
Mol Neurodegener. 2025 Jun 4;20(1):64. doi: 10.1186/s13024-025-00851-y.
3
Single-cell RNA-sequencing reveals early mitochondrial dysfunction unique to motor neurons shared across FUS- and TARDBP-ALS.

本文引用的文献

1
FUS-regulated region- and cell-type-specific transcriptome is associated with cell selectivity in ALS/FTLD.FUS 调节的区域和细胞类型特异性转录组与 ALS/FTLD 中的细胞选择性相关。
Sci Rep. 2013;3:2388. doi: 10.1038/srep02388.
2
Fused in sarcoma (FUS) protein lacking nuclear localization signal (NLS) and major RNA binding motifs triggers proteinopathy and severe motor phenotype in transgenic mice.缺失核定位信号(NLS)和主要 RNA 结合基序的融合肉瘤(FUS)蛋白在转基因小鼠中引发蛋白病变和严重的运动表型。
J Biol Chem. 2013 Aug 30;288(35):25266-25274. doi: 10.1074/jbc.M113.492017. Epub 2013 Jul 18.
3
RNA dysfunction and aggrephagy at the centre of an amyotrophic lateral sclerosis/frontotemporal dementia disease continuum.
单细胞RNA测序揭示了FUS和TARDBP相关肌萎缩侧索硬化症中运动神经元特有的早期线粒体功能障碍。
Nat Commun. 2025 May 19;16(1):4633. doi: 10.1038/s41467-025-59679-1.
4
Schwann Cells in Neuromuscular Disorders: A Spotlight on Amyotrophic Lateral Sclerosis.神经肌肉疾病中的施万细胞:聚焦肌萎缩侧索硬化症
Cells. 2025 Jan 3;14(1):47. doi: 10.3390/cells14010047.
5
Gut microbiota immune cross-talk in amyotrophic lateral sclerosis.肠道微生物群与肌萎缩侧索硬化症的免疫交叉对话。
Neurotherapeutics. 2024 Oct;21(6):e00469. doi: 10.1016/j.neurot.2024.e00469. Epub 2024 Nov 6.
6
The Fault in Our Astrocytes - cause or casualties of proteinopathies of ALS/FTD and other neurodegenerative diseases?我们星形胶质细胞的缺陷——肌萎缩侧索硬化症/额颞叶痴呆及其他神经退行性疾病蛋白质病的病因还是受害者?
Front Mol Med. 2023 Feb 16;3:1075805. doi: 10.3389/fmmed.2023.1075805. eCollection 2023.
7
Updates on Disease Mechanisms and Therapeutics for Amyotrophic Lateral Sclerosis.肌萎缩侧索硬化症的发病机制和治疗学研究进展。
Cells. 2024 May 21;13(11):888. doi: 10.3390/cells13110888.
8
Hyperhidrosis as the initial symptom in FUS mutation-associated amyotrophic lateral sclerosis: a case report and comprehensive literature review.以汗腺分泌过多为首发症状的 FUS 突变相关性肌萎缩侧索硬化症:病例报告及文献复习
Neurol Sci. 2024 Apr;45(4):1523-1527. doi: 10.1007/s10072-023-07141-9. Epub 2023 Oct 31.
9
Abl kinase-mediated FUS Tyr526 phosphorylation alters nucleocytoplasmic FUS localization in FTLD-FUS. Abl 激酶介导的 FUS Tyr526 磷酸化改变 FTLD-FUS 中的核质 FUS 定位。
Brain. 2023 Oct 3;146(10):4088-4104. doi: 10.1093/brain/awad130.
10
Zebrafish as a model organism for neurodegenerative disease.斑马鱼作为神经退行性疾病的模式生物。
Front Mol Neurosci. 2022 Oct 13;15:940484. doi: 10.3389/fnmol.2022.940484. eCollection 2022.
RNA 功能障碍和聚集物自噬在肌萎缩侧索硬化症/额颞叶痴呆疾病连续体的中心。
Brain. 2013 May;136(Pt 5):1345-60. doi: 10.1093/brain/awt030. Epub 2013 Mar 9.
4
Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS.朊病毒样结构域中的突变导致 hnRNPA2B1 和 hnRNPA1 的多系统蛋白病和 ALS。
Nature. 2013 Mar 28;495(7442):467-73. doi: 10.1038/nature11922. Epub 2013 Mar 3.
5
Spliceosome integrity is defective in the motor neuron diseases ALS and SMA.剪接体完整性在运动神经元疾病 ALS 和 SMA 中存在缺陷。
EMBO Mol Med. 2013 Feb;5(2):221-34. doi: 10.1002/emmm.201202303. Epub 2013 Jan 25.
6
Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs.ALS 相关蛋白 FUS/TLS 和 TDP-43 具有不同的功能,它们在加工长的前体 mRNA 方面存在交集。
Nat Neurosci. 2012 Nov;15(11):1488-97. doi: 10.1038/nn.3230. Epub 2012 Sep 30.
7
FUS-SMN protein interactions link the motor neuron diseases ALS and SMA.FUS-SMN 蛋白相互作用将运动神经元疾病 ALS 和 SMA 联系起来。
Cell Rep. 2012 Oct 25;2(4):799-806. doi: 10.1016/j.celrep.2012.08.025. Epub 2012 Sep 27.
8
Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion.人野生型 FUS 的过表达以年龄和剂量依赖的方式引起进行性运动神经元变性。
Acta Neuropathol. 2013 Feb;125(2):273-88. doi: 10.1007/s00401-012-1043-z. Epub 2012 Sep 9.
9
Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain.FUS 在新生 RNA 上的广泛结合调节大脑中的可变剪接。
Sci Rep. 2012;2:603. doi: 10.1038/srep00603. Epub 2012 Aug 28.
10
Exome sequencing identifies FUS mutations as a cause of essential tremor.外显子组测序发现 FUS 突变是原发性震颤的病因。
Am J Hum Genet. 2012 Aug 10;91(2):313-9. doi: 10.1016/j.ajhg.2012.07.002. Epub 2012 Aug 2.